JYMed Peptide

JYMed Peptide is a peptide-focused CDMO that supports programs from early R&D through GMP API manufacturing and finished dosage forms. Its services are described as spanning milligram-scale research peptides to multi-kilogram and metric-ton GMP production.

Manufacturing and capacity

• 13 cGMP production lines and 85,000 L of SPPS/LPPS reactor volume at its Hubei API site, which the company describes as delivering 10+ tons annually.
• Flexible batch sizes from 1 g R&D to 100 kg commercial batches, supported by OEB-5 containment, automation and real-time QC.
• Complex peptide synthesis including long chains, non-natural amino acids and conjugates.

Development and analytics

• A 7,000 m² Shenzhen R&D Center supporting peptide discovery, process development and advanced analytical testing, described as integrated with the CDMO workflow.
• Peptide formulation platforms and a JY FIS purification platform are listed among its technologies.

Finished dosage forms

• The Shenzhen FDF site handles syringe and cartridge filling, lyophilization and automated packaging.

Regulatory

• The company states that FDA, NMPA and EDQM inspections have been passed across multiple sites, and that some APIs have Drug Master Files registered with the U.S. FDA.

JYMed Peptide also supplies cosmetic and veterinary peptides, which are presented alongside its pharmaceutical CDMO and API business.